51.24
Exelixis Inc 주식(EXEL)의 최신 뉴스
EXEL Investors Have Opportunity to Join Exelixis, Inc. Fraud Investigation with SBS Law - The AI Journal
EXEL|Exelixis Inc|Price:50.990| - TradingKey
Farallon Capital (EXEL) discloses 13.99M-share Exelixis stake at $308M cost - Stock Titan
Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving Exelixis (EXEL) - globenewswire.com
Exelixis Inc (EXEL) Director Mary Beckerle Sells 9,812 Shares - GuruFocus
Annex Advisory Services LLC Makes New Investment in Exelixis, Inc. $EXEL - MarketBeat
Exelixis, Inc. (EXEL) Stock Forecasts - Yahoo! Finance Canada
Exelixis director Mary Beckerle sells $526k in shares - Investing.com
Exelixis director Mary Beckerle sells $526k in shares By Investing.com - Investing.com South Africa
Insider Selling: Exelixis (NASDAQ:EXEL) Director Sells $526,511.92 in Stock - MarketBeat
Exelixis (EXEL) Q2 2026 Earnings Call Transcript - The Globe and Mail
Exelixis (EXEL) director Beckerle sells 9,812 shares via Rule 10b5-1 plan - Stock Titan
EXEL Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Exelixis (EXEL) - Business Wire
AQR Capital discloses 11.0M-share Exelixis (EXEL) position at 4.39% ownership - Stock Titan
EXEL SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Exelixis - PR Newswire
Exelixis (EXEL) Short Interest & Short Float | Updated Aug 2026 - MarketBeat
Exelixis Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Exelixis (EXEL) - PR Newswire
EXELIXIS, INC. SEC Filing (Aug 10, 2026) - stocktitan.net
Exelixis, Inc. (EXEL) Stock Analysis: Exploring Growth Potential in Oncology with a Strong ROE - DirectorsTalk Interviews
Bank of America Corp DE Sells 578,181 Shares of Exelixis, Inc. $EXEL - MarketBeat
Exelixis, Inc. $EXEL Shares Acquired by Assenagon Asset Management S.A. - MarketBeat
Exelixis Inc (EXEL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
EXELIXIS INCDRN (E2XE34.SA) Q1 FY2026 earnings call transcript - Yahoo Finance
Amundi Sells 121,348 Shares of Exelixis, Inc. $EXEL - MarketBeat
Exelixis (NASDAQ:EXEL) Lowered to "Buy" Rating by Wall Street Zen - MarketBeat
Exelixis Inc (EXEL) Stock News Today - TradingKey
Quantinno Capital Management LP Boosts Holdings in Exelixis, Inc. $EXEL - MarketBeat
Exelixis (EXEL) Stock Drops As Guidance Cut Clouds Profit Strength - Sahm
EXELIXIS INC EXELIXIS ORD SHS (0IJO.L) Q4 FY2025 earnings call transcript - Yahoo Finance
Exelixis (EXEL) Is Down 6.7% After Cutting 2026 Revenue Outlook Amid Oncology Investment Pivot - Yahoo Finance
Exelixis, Inc. Stock 12‑Month Price Target Raised to $52.62, Implies 7% Downside - TradingView
EXELIXIS INC : LEERINK PARTNERS CUTS TO MARKET PERFORM FROM OUTPERFORM - Bitget
Exelixis (NASDAQ:EXEL) Rating Lowered to "Market Perform" at Leerink Partners - MarketBeat
EXEL Maintained by Truist Securities -- Price Target Lowered to $52.00 - GuruFocus
EXEL Tops Q2 Earnings Estimates, Misses on Sales, Lowers '26 View - Yahoo Finance
Stifel Nicolaus Issues Positive Forecast for Exelixis (NASDAQ:EXEL) Stock Price - MarketBeat
Exelixis, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:EXEL) 2026-08-06 - Seeking Alpha
Zacks Research Predicts Exelixis' Q3 Earnings (NASDAQ:EXEL) - marketbeat.com
Exelixis Inc (EXEL) (Q2 2026) Earnings Call Highlights: Strong C - GuruFocus
EXELIXIS INC : STIFEL RAISES TARGET PRICE TO $51 FROM $47 - Bitget
Exelixis Q2 Earnings Call Highlights - MarketBeat
Exelixis (NASDAQ:EXEL) Releases Quarterly Earnings Results, Beats Estimates By $0.06 EPS - MarketBeat
Exelixis (EXEL) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance
Exelixis Inc (EXEL) Beats EPS Estimate with $0.82 and Reports Re - GuruFocus
Transcript : Exelixis, Inc., Q2 2026 Earnings Call, Aug 05, 2026 - marketscreener.com
Earnings call transcript: Exelixis tops q2 2026 EPS view, shares fall after hours - Investing.com
Exelixis (EXEL) Tops Q2 Earnings Estimates - Yahoo Finance
Exelixis Inc reports results for the quarter ended March 31Earnings Summary - TradingView
EXELIXIS INC EXELIXIS ORD SHS (0IJO.L) Q2 FY2026 earnings call transcript - finance.yahoo.com
(EXEL) Exelixis Now Expects Fiscal 2026 Revenue Range $2.50B-$2.55B, vs. FactSet Est of $2.60B - marketscreener.com
Earnings Flash (EXEL) Exelixis, Inc. Reports Q2 Revenue $628.7M, vs. FactSet Est of $636.4M - marketscreener.com
Earnings Flash (EXEL) Exelixis Posts Q2 Revenue $628.7M, vs. FactSet Est of $636.4M - marketscreener.com
Exelixis Q2 Adjusted Earnings, Revenue Rise; Shares Drop After Hours - marketscreener.com
Exelixis: Q2 Earnings Snapshot - Yahoo Finance
Exelixis Q2 2026 earnings: Cabozantinib growth lifts revenue and EPS - TradingKey
EXELIXIS, INC. Q2 2026: Revenue $628.69M, EPS $0.82— 10-Q Summary - TradingView
Exelixis (NASDAQ: EXEL) grows Q2 sales to $628.7M as pipeline advances - Stock Titan
Exelixis, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Exelixis posts Q2 2026 revenue $628.7M, GAAP diluted EPS $0.82; updates 2026 guidance - TradingView
Earnings Flash (EXEL) Exelixis, Inc. Posts Q2 Adjusted EPS $0.91 per Share, vs. FactSet Est of $0.85 - marketscreener.com
Exelixis Announces Second Quarter 2026 Financial Results and Provides Corporate Update - marketscreener.com
Exelixis, Inc. Updates Earnings Guidance for Fiscal Year 2026 - marketscreener.com
Exelixis earnings on deck as generic threat looms By Investing.com - Investing.com Nigeria
Exelixis earnings on deck as generic threat looms - Investing.com
Royal Bank of Canada Grows Stock Holdings in Exelixis, Inc. $EXEL - MarketBeat
Exelixis (NASDAQ:EXEL) Cut to Strong Sell at Zacks Research - MarketBeat
Zacks Research Forecasts Exelixis' Q4 Earnings (NASDAQ:EXEL) - MarketBeat
자본화:
|
볼륨(24시간):